Éric Chevalier

1.2k total citations
30 papers, 892 citations indexed

About

Éric Chevalier is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Éric Chevalier has authored 30 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in Éric Chevalier's work include Chemokine receptors and signaling (7 papers), Immune cells in cancer (5 papers) and Immunotherapy and Immune Responses (3 papers). Éric Chevalier is often cited by papers focused on Chemokine receptors and signaling (7 papers), Immune cells in cancer (5 papers) and Immunotherapy and Immune Responses (3 papers). Éric Chevalier collaborates with scholars based in United States, France and Germany. Éric Chevalier's co-authors include Daniel P. Matton, Daniel Obrecht, Kerstin Moehle, Klaus Dembowsky, Pierre Rivière, Jean‐Louis Junien, X. Pascaud, Xuesong Wu, Sam T. Hwang and Glenn E. Dale and has published in prestigious journals such as Circulation, Blood and The Journal of Immunology.

In The Last Decade

Éric Chevalier

30 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Éric Chevalier United States 20 426 224 221 120 92 30 892
Lora M. Green United States 12 449 1.1× 121 0.5× 144 0.7× 74 0.6× 34 0.4× 27 905
Chanchal Sadhu United States 17 551 1.3× 146 0.7× 326 1.5× 89 0.7× 51 0.6× 31 1.2k
Hiroko Nagase United States 12 623 1.5× 106 0.5× 422 1.9× 188 1.6× 44 0.5× 14 1.1k
Michel Lacasa France 20 659 1.5× 366 1.6× 95 0.4× 149 1.2× 29 0.3× 37 1.4k
Huihui Ma China 22 493 1.2× 229 1.0× 258 1.2× 68 0.6× 31 0.3× 66 1.2k
Renier Myburgh Switzerland 17 486 1.1× 259 1.2× 210 1.0× 233 1.9× 33 0.4× 34 1.2k
Sonja Andersen Norway 16 840 2.0× 197 0.9× 225 1.0× 94 0.8× 49 0.5× 23 1.3k
Fei Zhou China 19 562 1.3× 158 0.7× 134 0.6× 94 0.8× 30 0.3× 54 977
Takashi Ohama Japan 22 687 1.6× 284 1.3× 122 0.6× 101 0.8× 29 0.3× 54 1.2k

Countries citing papers authored by Éric Chevalier

Since Specialization
Citations

This map shows the geographic impact of Éric Chevalier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Chevalier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Chevalier more than expected).

Fields of papers citing papers by Éric Chevalier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Chevalier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Chevalier. The network helps show where Éric Chevalier may publish in the future.

Co-authorship network of co-authors of Éric Chevalier

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Chevalier. A scholar is included among the top collaborators of Éric Chevalier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Chevalier. Éric Chevalier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keir, Holly R., Christopher J. Fong, Megan Crichton, et al.. (2019). Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition. ERJ Open Research. 5(1). 252–2018. 20 indexed citations
2.
Karpova, Darja, Susanne Bräuninger, Eliza Wiercinska, et al.. (2017). Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers—results of a dose escalation trial. Journal of Translational Medicine. 15(1). 2–2. 36 indexed citations
3.
Luther, Anatol, Kerstin Moehle, Éric Chevalier, Glenn E. Dale, & Daniel Obrecht. (2017). Protein epitope mimetic macrocycles as biopharmaceuticals. Current Opinion in Chemical Biology. 38. 45–51. 53 indexed citations
4.
Gagner, Jean‐Pierre, Yasmeen Sarfraz, Valerio Ortenzi, et al.. (2017). Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti–Vascular Endothelial Growth Factor Therapy–Induced Glioma Dissemination. American Journal Of Pathology. 187(9). 2080–2094. 34 indexed citations
5.
Xiang, Jingyu, Michelle A. Hurchla, Francesca Fontana, et al.. (2015). CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 14(11). 2473–2485. 49 indexed citations
6.
Daubeuf, François, et al.. (2015). Protective effect of a Protein Epitope Mimetic CCR10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation. Respiratory Research. 16(1). 77–77. 12 indexed citations
7.
Wach, Achim, et al.. (2013). Inhibition of lung inflammation by a protein epitope mimetic (PEM) neutrophil elastase inhibitor, POL6014, in a sub-chronic tobacco smoke (TS) model in mice. European Respiratory Journal. 42(Suppl 57). 1762–1762. 1 indexed citations
8.
Hamesch, Karim, Pallavi Subramanian, Xiaofeng Li, et al.. (2012). The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation. Thrombosis and Haemostasis. 107(2). 356–368. 23 indexed citations
9.
Sison, Edward Allan R., Daniel Magoon, Éric Chevalier, Klaus Dembowsky, & Patrick A. Brown. (2012). The Novel CXCR4 Antagonist POL5551 Decreases Surface CXCR4 (s-CXCR4) Expression, Inhibits Chemotaxis, and Enhances Chemosensitivity in Acute Lymphoblastic Leukemia (ALL). Blood. 120(21). 780–780. 1 indexed citations
10.
Chevalier, Éric, et al.. (2011). Cell–cell communication and signalling pathways within the ovule: from its inception to fertilization. New Phytologist. 192(1). 13–28. 41 indexed citations
11.
Mete, Antonio, Keith Bowers, Éric Chevalier, et al.. (2011). The discovery of AZD9164, a novel muscarinic M3 antagonist. Bioorganic & Medicinal Chemistry Letters. 21(24). 7440–7446. 13 indexed citations
12.
Wu, Xuesong, et al.. (2009). Chemokine Receptors as Targets for Cancer Therapy. Current Pharmaceutical Design. 15(7). 742–757. 54 indexed citations
13.
Germain, Hugo, Éric Chevalier, & Daniel P. Matton. (2006). Plant bioactive peptides: an expanding class of signaling molecules. Canadian Journal of Botany. 84(1). 1–19. 19 indexed citations
14.
Chevalier, Éric, Jeff Stock, Timothy S. Fisher, et al.. (2005). Cutting Edge: Chemoattractant Receptor-Homologous Molecule Expressed on TH2 Cells Plays a Restricting Role on IL-5 Production and Eosinophil Recruitment. The Journal of Immunology. 175(4). 2056–2060. 69 indexed citations
15.
Bernardelli, Patrick, Edwige Lorthiois, Pierre Ducrot, et al.. (2004). Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 2: Optimization of 5,8-disubstituted derivatives. Bioorganic & Medicinal Chemistry Letters. 14(18). 4627–4631. 24 indexed citations
16.
Bernardelli, Patrick, Edwige Lorthiois, Pierre Ducrot, et al.. (2004). Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 2: Metabolism-directed optimization studies towards orally bioavailable derivatives. Bioorganic & Medicinal Chemistry Letters. 14(18). 4615–4621. 28 indexed citations
17.
Chevalier, Éric, et al.. (2004). Beneficial effect of trimebutine and N-monodesmethyl trimebutine on trinitrobenzene sulfonic acid-induced colitis in rats. Life Sciences. 76(3). 319–329. 9 indexed citations
18.
Diop, Laurent, et al.. (1997). Involvement of prostaglandins and CGRP-dependent sensory afferents in peritoneal irritation-induced visceral pain. Regulatory Peptides. 70(1). 1–7. 36 indexed citations
19.
Rivière, Pierre, et al.. (1993). Fedotozine reverses ileus induced by surgery or peritonitis: Action at peripheral Κ-Opioid receptors. Gastroenterology. 104(3). 724–731. 62 indexed citations
20.
Pascaud, X., et al.. (1993). Effects of a new σ ligand, JO 1784, on cysteamine ulcers and duodenal alkaline secretion in rats. Gastroenterology. 104(2). 427–434. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lora M. Green Breakdown of academic impact, for papers by Chanchal Sadhu Breakdown of academic impact, for papers by Hiroko Nagase Breakdown of academic impact, for papers by Michel Lacasa Breakdown of academic impact, for papers by Huihui Ma Breakdown of academic impact, for papers by Renier Myburgh Breakdown of academic impact, for papers by Sonja Andersen Breakdown of academic impact, for papers by Fei Zhou Breakdown of academic impact, for papers by Takashi Ohama
Rankless by CCL
2026